SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of
the WpHG (the German Securities Trading Act) with the objective of Europe-wide
distribution
EQS Voting Rights Announcement: SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of
the WpHG (the German Securities Trading Act) with the objective of
Europe-wide distribution
23.05.2024 / 07:00 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Notification of Major Holdings
1. Details of issuer
Name: SCHOTT Pharma AG & Co. KGaA
Street: Hattenbergstraße 10
Postal code: 55122
City: Mainz
Germany
Legal Entity Identifier (LEI): 529900TU48UE99NHEY88
2. Reason for notification
X Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
Change of breakdown of voting rights
Other reason:
3. Details of person subject to the notification obligation
Legal entity: SMALLCAP World Fund, Inc.
City of registered office, country: Lutherville Timonium, United
States of America (USA)
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached:
17 May 2024
6. Total positions
% of voting % of voting rights Total of Total number of
rights attached through both in % voting rights
to shares instruments (total (7.a. + pursuant to
(total of 7.a.) of 7.b.1 + 7.b.2) 7.b.) Sec. 41 WpHG
New 2.96 % 0.34 % 3.30 % 150614616
Previo- 3.06 % 0.17 % 3.23 % /
us
notifi-
cation
7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
Direct (Sec. Indirect (Sec. Direct (Sec. Indirect
33 WpHG) 34 WpHG) 33 WpHG) (Sec. 34
WpHG)
DE000A3ENQ51 4456812 0 2.96 % 0 %
Total 4456812 2.96 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of Expiration or Exercise or Voting Voting
instrument maturity date conversion rights rights in
period absolute %
0 0 %
Total 0 0.00 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of Expiration Exercise or Cash or Voting Voting
instrument or conversion physical rights rights
maturity period settlement absolute in %
date
Rights to recall Physical 510429 0.34 %
lent shares of settlement
Common Stock
Total 510429 0.34 %
8. Information in relation to the person subject to the notification
obligation
X Person subject to the notification obligation is not controlled nor
does it control any other undertaking(s) that directly or
indirectly hold(s) an interest in the (underlying) issuer (1.).
Full chain of controlled undertakings starting with the ultimate
controlling natural person or legal entity:
Name % of voting rights % of voting rights Total of both (if
(if at least 3% or through instruments (if at least 5% or
more) at least 5% or more) more)
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34
para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general
meeting:
Proportion of voting Proportion of Total of
rights instruments both
% % %
10. Other explanatory remarks:
Date
20 May 2024
---------------------------------------------------------------------------
23.05.2024 CET/CEST The EQS Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
---------------------------------------------------------------------------
Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany
End of News EQS News Service
---------------------------------------------------------------------------
1909225 23.05.2024 CET/CEST